-
4
-
-
0348108289
-
Ethnic/racial influences on the physiologic health of cancer survivors
-
Schultz PN, Stava C, Beck ML, Vassilopoulou-Sellin R. Ethnic/racial influences on the physiologic health of cancer survivors. Cancer 2004;100:156-64.
-
(2004)
Cancer
, vol.100
, pp. 156-64
-
-
Schultz, P.N.1
Stava, C.2
Beck, M.L.3
Vassilopoulou-Sellin, R.4
-
5
-
-
33750036689
-
Health profiles of younger and older breast cancer survivors
-
Stava CJ, Lopez A, Vassilopoulou-Sellin R. Health profiles of younger and older breast cancer survivors. Cancer 2006;107:1752-9.
-
(2006)
Cancer
, vol.107
, pp. 1752-9
-
-
Stava, C.J.1
Lopez, A.2
Vassilopoulou-Sellin, R.3
-
7
-
-
13444270652
-
Breast cancer: Relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors
-
Schultz PN, Klein MJ, Beck ML, Stava C, Sellin RV. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. J Clin Nurs 2005;14:204-11.
-
(2005)
J Clin Nurs
, vol.14
, pp. 204-11
-
-
Schultz, P.N.1
Klein, M.J.2
Beck, M.L.3
Stava, C.4
Sellin, R.V.5
-
9
-
-
34250186080
-
Diabetes mellitus among cancer survivors
-
Stava C, Beck ML, Feng L, Lopez A, Busaidy N, Vassilopoulou-Sellin R. Diabetes mellitus among cancer survivors. J Can Surviv 2007;1:102-115.
-
(2007)
J Can Surviv
, vol.1
, pp. 102-115
-
-
Stava, C.1
Beck, M.L.2
Feng, L.3
Lopez, A.4
Busaidy, N.5
Vassilopoulou-Sellin, R.6
-
10
-
-
0344511761
-
Health profiles and quality of life of 518 survivors of thyroid cancer
-
Schultz PN, Stava C, Vassilopoulou-Sellin R. Health profiles and quality of life of 518 survivors of thyroid cancer. Head Neck 2003;25:349-56.
-
(2003)
Head Neck
, vol.25
, pp. 349-56
-
-
Schultz, P.N.1
Stava, C.2
Vassilopoulou-Sellin, R.3
-
11
-
-
23444457947
-
Endocrine late effects of cancer treatment
-
Cohen LE. Endocrine late effects of cancer treatment. Endocrinol Metab Clin North Am 2005;34:769-89.
-
(2005)
Endocrinol Metab Clin North Am
, vol.34
, pp. 769-89
-
-
Cohen, L.E.1
-
14
-
-
0033432714
-
Overview of the effects of cancer therapies; The nature, scale and breadth of the problem
-
Sklar CA. Overview of the effects of cancer therapies; the nature, scale and breadth of the problem. Acta Paediatr Suppl 1999;88:1-4.
-
(1999)
Acta Paediatr Suppl
, vol.88
, pp. 1-4
-
-
Sklar, C.A.1
-
15
-
-
23644434572
-
Endocrine late effects from mult-modality treatment of neuroblastoma
-
Van Santen HM, de Kraker K, Vulsma T. Endocrine late effects from mult-modality treatment of neuroblastoma. Eur J Cancer 2005;41:1767-74.
-
(2005)
Eur J Cancer
, vol.41
, pp. 1767-74
-
-
Van Santen, H.M.1
De Kraker, K.2
Vulsma, T.3
-
16
-
-
3142679473
-
Hypothalamic dysfunction after chemotherapy
-
Rose SR, Schreiber RE, Kearney NS, Lustig RH, Danish RK, Burghen GA, et al. Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 2004;17:55-66.
-
(2004)
J Pediatr Endocrinol Metab
, vol.17
, pp. 55-66
-
-
Rose, S.R.1
Schreiber, R.E.2
Kearney, N.S.3
Lustig, R.H.4
Danish, R.K.5
Burghen, G.A.6
-
17
-
-
0032452430
-
The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors
-
Kaltsas GA, Mukherjee JJ, Plowman PN, Monson JP, Grossman AB, Besser GM. The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors. J Clin Endocrinol Metab 1998;83:4233-38.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 4233-38
-
-
Kaltsas, G.A.1
Mukherjee, J.J.2
Plowman, P.N.3
Monson, J.P.4
Grossman, A.B.5
Besser, G.M.6
-
18
-
-
2542584573
-
Endocrine consequences of brain irradiation
-
Suppl A
-
Toogood AA. Endocrine consequences of brain irradiation. Growth Horm IGF Res 2004;14(Suppl A):S118-24.
-
(2004)
Growth Horm IGF Res
, vol.14
, pp. 118-24
-
-
Toogood, A.A.1
-
19
-
-
28744436684
-
Hypothalamic-pituitary dysfunction after irradiation of non-pituitary brain tumors in adults
-
Agha A, Sherlock M, Brennan S, O, Connor SA, O, Sullivan E, Rogers B, et al. Hypothalamic-pituitary dysfunction after irradiation of non-pituitary brain tumors in adults. J Clin Endocrinol Metab 2005;90:6355-60.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 6355-60
-
-
Agha, A.1
Sherlock, M.2
Brennan, S.O.3
Connor, S.A.O.4
Sullivan, E.5
Rogers, B.6
-
20
-
-
0037317911
-
Interferon-induced hypopituitarism
-
Concha LB, Carlson HE, Heimann A, Lake-Bakaar GV, Paal AF. Interferon-induced hypopituitarism. Am J Med 2003;114:161-3.
-
(2003)
Am J Med
, vol.114
, pp. 161-3
-
-
Concha, L.B.1
Carlson, H.E.2
Heimann, A.3
Lake-Bakaar, G.V.4
Paal, A.F.5
-
21
-
-
1842762908
-
Panhypopituitarism in association with interferon-alpha treatment
-
Chan WB, Cockram CS. Panhypopituitarism in association with interferon-alpha treatment. Singap Med J 2004;45:93-4.
-
(2004)
Singap Med J
, vol.45
, pp. 93-4
-
-
Chan, W.B.1
Cockram, C.S.2
-
22
-
-
34248199320
-
Long-term follow up of patients with pituitary macroadenomas after postoperative radiation therapy: Analysis of tumor control and functional outcome
-
Langsenlehner T, Stiegler C, Quehenberger F, Feigl GC, Jakse G, Mokry M, et al. Long-term follow up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. Strahlenther Onkol 2007;183:241-7.
-
(2007)
Strahlenther Onkol
, vol.183
, pp. 241-7
-
-
Langsenlehner, T.1
Stiegler, C.2
Quehenberger, F.3
Feigl, G.C.4
Jakse, G.5
Mokry, M.6
-
23
-
-
13444312158
-
The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas
-
Minniti G, Jaffrain-Rea M, Osti M, Esposito V, Santoro A, Solda F, et al. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol 2005;62:210-6.
-
(2005)
Clin Endocrinol
, vol.62
, pp. 210-6
-
-
Minniti, G.1
Jaffrain-Rea, M.2
Osti, M.3
Esposito, V.4
Santoro, A.5
Solda, F.6
-
24
-
-
0031015129
-
Hypothalamic-pituitary-adrenal function following cranial irradiation
-
Oberfield SE, Nirenberg A, Allen JC, Cohen H, Donahue B, Prasad V, et al. Hypothalamic-pituitary-adrenal function following cranial irradiation. Horm Res 1997;47:9-16.
-
(1997)
Horm Res
, vol.47
, pp. 9-16
-
-
Oberfield, S.E.1
Nirenberg, A.2
Allen, J.C.3
Cohen, H.4
Donahue, B.5
Prasad, V.6
-
25
-
-
0037397137
-
Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours
-
Spoudeas HA, Charmandari E, Brook CG. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours. Med Pediatr Oncol 2003;40:224-9.
-
(2003)
Med Pediatr Oncol
, vol.40
, pp. 224-9
-
-
Spoudeas, H.A.1
Charmandari, E.2
Brook, C.G.3
-
26
-
-
0029093260
-
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease
-
Sorensen JB, Andersen MK, Hansen HH. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 1995;238:97-110.
-
(1995)
J Intern Med
, vol.238
, pp. 97-110
-
-
Sorensen, J.B.1
Andersen, M.K.2
Hansen, H.H.3
-
27
-
-
0036929354
-
Syndrome of inappropriate secretion of antidiuretic hormone induced by intraarterial cistplatin therapy
-
Ishii K, Aoki Y, Sasaki M, Tanaka K. Syndrome of inappropriate secretion of antidiuretic hormone induced by intraarterial cistplatin therapy. Gynecol Oncol 2002;87:150-1.
-
(2002)
Gynecol Oncol
, vol.87
, pp. 150-1
-
-
Ishii, K.1
Aoki, Y.2
Sasaki, M.3
Tanaka, K.4
-
28
-
-
6044268098
-
The syndrome of inappropriate antidiuretic hormone secretion associated with chemotherapy for hypophayryngeal cancer
-
Kusuki M, Iguchi H, Nakamura A, Nishiura H, Kanazawa A, Yamane H. The syndrome of inappropriate antidiuretic hormone secretion associated with chemotherapy for hypophayryngeal cancer. Acta Otolaryngol Suppl 2004;554:74-7.
-
(2004)
Acta Otolaryngol Suppl
, vol.554
, pp. 74-7
-
-
Kusuki, M.1
Iguchi, H.2
Nakamura, A.3
Nishiura, H.4
Kanazawa, A.5
Yamane, H.6
-
29
-
-
13744252804
-
Syndrome of inappropriate secretion of antidiuretic hormone suddenly occurring in a case following chemotherapy
-
Yamomoto Y, Kokubo A, Yonekawa M, Nakanishi K. Syndrome of inappropriate secretion of antidiuretic hormone suddenly occurring in a case following chemotherapy. Gan To Kagaku Ryoho 2005;32:107-9.
-
(2005)
Gan to Kagaku Ryoho
, vol.32
, pp. 107-9
-
-
Yamomoto, Y.1
Kokubo, A.2
Yonekawa, M.3
Nakanishi, K.4
-
30
-
-
0029929075
-
Syndrome of inappropriate secretion of antidiuretic hormone following intrathoracic cisplatin
-
Otsuka F, Hayashi Y, Ogura T, Hayakawa N, Ikeda S, Makino H, et al. Syndrome of inappropriate secretion of antidiuretic hormone following intrathoracic cisplatin. Intern Med 1996;35:290-4.
-
(1996)
Intern Med
, vol.35
, pp. 290-4
-
-
Otsuka, F.1
Hayashi, Y.2
Ogura, T.3
Hayakawa, N.4
Ikeda, S.5
Makino, H.6
-
31
-
-
0018862393
-
Inappropriate ADH secretion caused by oat cell carcinoma and relieved by lung resection
-
Robinson C, Jeffries RC, Walsh GC. Inappropriate ADH secretion caused by oat cell carcinoma and relieved by lung resection. Thorax 1980;35:635-7.
-
(1980)
Thorax
, vol.35
, pp. 635-7
-
-
Robinson, C.1
Jeffries, R.C.2
Walsh, G.C.3
-
32
-
-
0031779356
-
Ifosfamide-induced renal Franconi syndrome with associated nephrogenic diabetes insipidus in an adult patient
-
Negro A, Regolisti G, Perazzoli F, Davili S, Sani C, Rossi E. Ifosfamide-induced renal Franconi syndrome with associated nephrogenic diabetes insipidus in an adult patient. Nephrol Dial Transplant 1998;13:1547-9.
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 1547-9
-
-
Negro, A.1
Regolisti, G.2
Perazzoli, F.3
Davili, S.4
Sani, C.5
Rossi, E.6
-
33
-
-
0029092329
-
Concentrating capacity in ifosfamide-induced severe renal dysfunction
-
Rossi R, Gödde A, Kleinebrand A, Rath B, Jürgens H. Concentrating capacity in ifosfamide-induced severe renal dysfunction. Ren Fail 1995;17:551-7.
-
(1995)
Ren Fail
, vol.17
, pp. 551-7
-
-
Rossi, R.1
Gödde, A.2
Kleinebrand, A.3
Rath, B.4
Jürgens, H.5
-
34
-
-
0030608224
-
Risk factors for ifosfamide nephrotoxicity in children
-
Sinner R, Pearson AD, English MW, Price L, Wyllie RA, Coulthard MG, et al. Risk factors for ifosfamide nephrotoxicity in children. Lancet 1996;348:578-80.
-
(1996)
Lancet
, vol.348
, pp. 578-80
-
-
Sinner, R.1
Pearson, A.D.2
English, M.W.3
Price, L.4
Wyllie, R.A.5
Coulthard, M.G.6
-
35
-
-
0015123582
-
Further studies on streptozotocin therapy for a multiple-hormone producing islet cell carcinoma
-
Murray-Lyon IM, Cassar J, Coulson R, Williams R, Ganguli PC, Edwards JC, et al. Further studies on streptozotocin therapy for a multiple-hormone producing islet cell carcinoma. Gut 1971;12:717-20.
-
(1971)
Gut
, vol.12
, pp. 717-20
-
-
Murray-Lyon, I.M.1
Cassar, J.2
Coulson, R.3
Williams, R.4
Ganguli, P.C.5
Edwards, J.C.6
-
36
-
-
0023124589
-
Indomethacin in streptozocin-induced nephrogenic diabetes insipidus
-
Delaney V, de Pertuz Y, Nixon D, Bourke E. Indomethacin in streptozocin-induced nephrogenic diabetes insipidus. Am J Kidney Dis 1987;9:79-83.
-
(1987)
Am J Kidney Dis
, vol.9
, pp. 79-83
-
-
Delaney, V.1
De Pertuz, Y.2
Nixon, D.3
Bourke, E.4
-
37
-
-
11244315128
-
The impact of cancer therapy on the endocrine system in survivors of childhood brain tumors
-
Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumors. Endocr Relat Cancer 2004;11:589-602.
-
(2004)
Endocr Relat Cancer
, vol.11
, pp. 589-602
-
-
Gleeson, H.K.1
Shalet, S.M.2
-
38
-
-
36749041627
-
Pituitary deficiency after brain radiation therapy
-
Borson-Chazot F, Brue T. Pituitary deficiency after brain radiation therapy. Ann Endocrinol (Paris) 2006;67:303-9.
-
(2006)
Ann Endocrinol (Paris)
, vol.67
, pp. 303-9
-
-
Borson-Chazot, F.1
Brue, T.2
-
39
-
-
7044284837
-
Radiation-induced brain disorders in patients with pituitary tumors
-
Bhansali A, Banerjee AK, Chanda A, Singh P, Sharma SC, Mathuriya SN, et al. Radiation-induced brain disorders in patients with pituitary tumors. Australas Radiol 2004;48:339-46.
-
(2004)
Australas Radiol
, vol.48
, pp. 339-46
-
-
Bhansali, A.1
Banerjee, A.K.2
Chanda, A.3
Singh, P.4
Sharma, S.C.5
Mathuriya, S.N.6
-
40
-
-
0034329065
-
Cranial irradiation- an unusual case for diabetes insipidus
-
Jyotsna VP, Singh SK, Chaturvedi R, Neogi B, Bhadada SK, Sahay RK, et al. Cranial irradiation- an unusual case for diabetes insipidus. J Assoc Physicians India 2000;48:1107-8.
-
(2000)
J Assoc Physicians India
, vol.48
, pp. 1107-8
-
-
Jyotsna, V.P.1
Singh, S.K.2
Chaturvedi, R.3
Neogi, B.4
Bhadada, S.K.5
Sahay, R.K.6
-
41
-
-
0033436283
-
Survivors of childhood cancer: Long-term endocrine and metabolic problems dwarf the growth disturbance
-
Murray RD, Brennan BM, Rahim A, Shalet SM. Survivors of childhood cancer: long-term endocrine and metabolic problems dwarf the growth disturbance. Acta Paediatr Suppl 1999;88:5-12.
-
(1999)
Acta Paediatr Suppl
, vol.88
, pp. 5-12
-
-
Murray, R.D.1
Brennan, B.M.2
Rahim, A.3
Shalet, S.M.4
-
42
-
-
0029057359
-
Chemotherapy-induced growth hormone deficiency in children with cancer
-
Román J, Villaizán CJ, García-Foncillas J, Azcona C, Salvador J, Sierrasesúmaga L. Chemotherapy-induced growth hormone deficiency in children with cancer. Med Pediatr Oncol 1995;25:90-5.
-
(1995)
Med Pediatr Oncol
, vol.25
, pp. 90-5
-
-
Román, J.1
Villaizán, C.J.2
García-Foncillas, J.3
Azcona, C.4
Salvador, J.5
Sierrasesúmaga, L.6
-
43
-
-
0026761316
-
The effects of adjuvant chemotherapy on growth in children with medulloblastoma
-
Olshan JS, Gubernick J, Packer RJ, D, Angio GJ, Goldwein JW, Willi SM, et al. The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 1992;70:2013-7.
-
(1992)
Cancer
, vol.70
, pp. 2013-7
-
-
Olshan, J.S.1
Gubernick, J.2
Packer, R.J.D.3
Angio, G.J.4
Goldwein, J.W.5
Willi, S.M.6
-
44
-
-
0025820459
-
A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia
-
Marky I, Mellander L, Lannering B, Albertsson-Wikland L. A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 1991;19:258-64.
-
(1991)
Med Pediatr Oncol
, vol.19
, pp. 258-64
-
-
Marky, I.1
Mellander, L.2
Lannering, B.3
Albertsson-Wikland, L.4
-
45
-
-
0031809541
-
Growth hormone status in adults treated for acute lymphoblastic leukemia in childhood
-
Brennan BM, Rahim A, Mackie EM, Eden OB, Shalet SM. Growth hormone status in adults treated for acute lymphoblastic leukemia in childhood. Clin Endocrinol (Oxf) 1998;48:777-83.
-
(1998)
Clin Endocrinol (Oxf)
, vol.48
, pp. 777-83
-
-
Brennan, B.M.1
Rahim, A.2
MacKie, E.M.3
Eden, O.B.4
Shalet, S.M.5
-
46
-
-
13544255575
-
Long-term endocrine effects of cancer treatment: Experience of the Royal Children's Hospital Melbourne
-
Hameed R, Zacharin MR. Long-term endocrine effects of cancer treatment: experience of the Royal Children's Hospital Melbourne. J Paediatr Child Health 2005;41:36-42.
-
(2005)
J Paediatr Child Health
, vol.41
, pp. 36-42
-
-
Hameed, R.1
Zacharin, M.R.2
-
47
-
-
0025232674
-
Endocrine disorders following treatment for childhood brain tumours
-
Livesey EA, Hindmarsh PC, Brook CG, Whitton AC, Bloom HJ, Tobias JS, et al. Endocrine disorders following treatment for childhood brain tumours. Br J Cancer 1990;61:622-5.
-
(1990)
Br J Cancer
, vol.61
, pp. 622-5
-
-
Livesey, E.A.1
Hindmarsh, P.C.2
Brook, C.G.3
Whitton, A.C.4
Bloom, H.J.5
Tobias, J.S.6
-
48
-
-
34250637636
-
Hyperprolactinemia: Causes, diagnosis, and treatment
-
article in Polish
-
Karasek M, Pawlikowski M, Lewinski A. Hyperprolactinemia: causes, diagnosis, and treatment. Endokrynol Pol 2006;57:656-62. (article in Polish).
-
(2006)
Endokrynol Pol
, vol.57
, pp. 656-62
-
-
Karasek, M.1
Pawlikowski, M.2
Lewinski, A.3
-
49
-
-
33645354069
-
Hypopituitarism as a consequence of brain tumors and radiotherapy
-
Darzy KH, Shalet SM. Hypopituitarism as a consequence of brain tumors and radiotherapy. Pituitary 2005;8:203-11.
-
(2005)
Pituitary
, vol.8
, pp. 203-11
-
-
Darzy, K.H.1
Shalet, S.M.2
-
50
-
-
0023610108
-
Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies
-
Constine LS, Rubin P, Woolf PD, Doane K, Lush CM. Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies. J Clin Oncol 1987;5:1841-51.
-
(1987)
J Clin Oncol
, vol.5
, pp. 1841-51
-
-
Constine, L.S.1
Rubin, P.2
Woolf, P.D.3
Doane, K.4
Lush, C.M.5
-
51
-
-
0027080051
-
Hypothalamic-pituitary dysfunction after radiation for brain tumors
-
Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Eng J Med 1993;328:87-94.
-
(1993)
N Eng J Med
, vol.328
, pp. 87-94
-
-
Constine, L.S.1
Woolf, P.D.2
Cann, D.3
Mick, G.4
McCormick, K.5
Raubertas, R.F.6
-
52
-
-
0027508035
-
Effect of radiation on the human reproductive system
-
Suppl 2
-
Ogilvy-Stuart AL, Shalet SM. Effect of radiation on the human reproductive system. Environ Health Perspect 1993;101(Suppl 2):109-16.
-
(1993)
Environ Health Perspect
, vol.101
, pp. 109-16
-
-
Ogilvy-Stuart, A.L.1
Shalet, S.M.2
-
53
-
-
20644449596
-
Section 40. Complications of cancer and its treatment, 155. Endocrine complications
-
5 BC Decker Inc. Hamilton, Ontario, Canada
-
Yeung SJ, Gagel RF. Section 40. Complications of cancer and its treatment, 155. Endocrine complications. In: Holland JF, Frei E III, Bast RC Jr, Kufe DW, Pollock RE, Weischselbaum RR, editors. Cancer medicine. 5th ed. Hamilton, Ontario, Canada: BC Decker Inc.; 2000.
-
(2000)
Cancer Medicine
-
-
Yeung, S.J.1
Gagel, R.F.2
Holland, J.F.3
Frei Iii, E.4
Bast Jr., R.C.5
Kufe, D.W.6
Pollock, R.E.7
Weischselbaum, R.R.8
-
54
-
-
0020414193
-
Effects of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors
-
Rappaport R, Brauner R, Czernichow P, Thibaud E, Renier D, Zucker JM, et al. Effects of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab 1982;54:1164-8.
-
(1982)
J Clin Endocrinol Metab
, vol.54
, pp. 1164-8
-
-
Rappaport, R.1
Brauner, R.2
Czernichow, P.3
Thibaud, E.4
Renier, D.5
Zucker, J.M.6
-
55
-
-
0022547272
-
Effect of the antileukemic agent l-asparaginase on thyroxine-binding globulin and albumin synthesis in cultured human hepatoma (HEP G2) cells
-
Bartalena L, Martino E, Antonelli A, Pacchiarotti A, Robbins J, Pinchera A. Effect of the antileukemic agent l-asparaginase on thyroxine-binding globulin and albumin synthesis in cultured human hepatoma (HEP G2) cells. Endocrinology 1986;119:1185-8.
-
(1986)
Endocrinology
, vol.119
, pp. 1185-8
-
-
Bartalena, L.1
Martino, E.2
Antonelli, A.3
Pacchiarotti, A.4
Robbins, J.5
Pinchera, A.6
-
56
-
-
0029650041
-
Drugs and thyroid function
-
Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med 1995;333:1688-94.
-
(1995)
N Engl J Med
, vol.333
, pp. 1688-94
-
-
Surks, M.I.1
Sievert, R.2
-
57
-
-
0034132016
-
How medications affect thyroid function
-
Dong BJ. How medications affect thyroid function. West J Med 2000;172:102-6.
-
(2000)
West J Med
, vol.172
, pp. 102-6
-
-
Dong, B.J.1
-
58
-
-
0028929933
-
Thyroid function test changes with adjuvant tamoxifen therapy in postmenopausal women with breast cancer
-
Mamby CC, Love RR, Lee KE. Thyroid function test changes with adjuvant tamoxifen therapy in postmenopausal women with breast cancer. J Clin Oncol 1995;13:854-7.
-
(1995)
J Clin Oncol
, vol.13
, pp. 854-7
-
-
Mamby, C.C.1
Love, R.R.2
Lee, K.E.3
-
59
-
-
0025173042
-
Direct effects of cytostatic therapy on the functional state of the thyroid gland and TBG in serum of patients
-
Djurica SN, Plećas B, Milojević Z, Petrović M, Cirović M, Tasovac-Ponomarev D. Direct effects of cytostatic therapy on the functional state of the thyroid gland and TBG in serum of patients. Exp Clin Endocrinol 1990;96:57-63.
-
(1990)
Exp Clin Endocrinol
, vol.96
, pp. 57-63
-
-
Djurica, S.N.1
Plećas, B.2
Milojević, Z.3
Petrović, M.4
Cirović, M.5
Tasovac-Ponomarev, D.6
-
60
-
-
0036643969
-
Hypothyroidism in children with medulloblastoma: A comparison of 3600 and 2340 cGy craniospinal radiotherapy
-
Paulino AC. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 2002;53:543-7.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.53
, pp. 543-7
-
-
Paulino, A.C.1
-
61
-
-
21844471529
-
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2
-
Chianese-Bullock KA, Woodson EM, Tao H, Boerner SA, Smolkin M, Grosh WW, et al. Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2. J Immunother 2005;28:412-9.
-
(2005)
J Immunother
, vol.28
, pp. 412-9
-
-
Chianese-Bullock, K.A.1
Woodson, E.M.2
Tao, H.3
Boerner, S.A.4
Smolkin, M.5
Grosh, W.W.6
-
62
-
-
33645233665
-
Interferon-alpha-induced hyperthyroidism: A three-stage evolution from silent thyroiditis towards Graves' disease
-
Bohbot NL, Young J, Orgiazzi J, Buffet C, François M, Bernard-Chabert B, et al. Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease. Eur J Endocrinol 2006;154:367-72.
-
(2006)
Eur J Endocrinol
, vol.154
, pp. 367-72
-
-
Bohbot, N.L.1
Young, J.2
Orgiazzi, J.3
Buffet, C.4
François, M.5
Bernard-Chabert, B.6
-
63
-
-
0027230543
-
Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response
-
Kruit WH, Bolhuis RL, Goey SH, Jansen RL, Eggermont AM, Batchelor D, et al. Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response. J Clin Oncol 1993;11:921-4.
-
(1993)
J Clin Oncol
, vol.11
, pp. 921-4
-
-
Kruit, W.H.1
Bolhuis, R.L.2
Goey, S.H.3
Jansen, R.L.4
Eggermont, A.M.5
Batchelor, D.6
-
64
-
-
34548764576
-
A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake
-
Mannavola D, Coco P, Vannucchi G, Bertuelli R, Carletto M, Casari P, et al. A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. J Clin Endocrinol Metab 2007;92:3531-4.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 3531-4
-
-
Mannavola, D.1
Coco, P.2
Vannucchi, G.3
Bertuelli, R.4
Carletto, M.5
Casari, P.6
-
65
-
-
33846978108
-
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
-
Rini BI, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, et al. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst 2007;99:81-3.
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 81-3
-
-
Rini, B.I.1
Tamaskar, I.2
Shaheen, P.3
Salas, R.4
Garcia, J.5
Wood, L.6
-
66
-
-
34248632840
-
Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity
-
Wong F, Rosen LS, Mulay M, Vanvught A, Dinolfo A, Tomoda C, et al. Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity. Thyroid 2007;17:351-5.
-
(2007)
Thyroid
, vol.17
, pp. 351-5
-
-
Wong, F.1
Rosen, L.S.2
Mulay, M.3
Vanvught, A.4
Dinolfo, A.5
Tomoda, C.6
-
67
-
-
33750961647
-
Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors
-
Desai J, Yassa L, Marqusee E, George S, Frates MC, Chen MH, et al. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 2006;145:660-4.
-
(2006)
Ann Intern Med
, vol.145
, pp. 660-4
-
-
Desai, J.1
Yassa, L.2
Marqusee, E.3
George, S.4
Frates, M.C.5
Chen, M.H.6
-
68
-
-
33750964250
-
Terminal ballistics of kinase inhibitors: There are no magic bullets
-
Maitland ML, Ratain MJ. Terminal ballistics of kinase inhibitors: there are no magic bullets. Ann Intern Med 2006;145:702-3.
-
(2006)
Ann Intern Med
, vol.145
, pp. 702-3
-
-
Maitland, M.L.1
Ratain, M.J.2
-
69
-
-
33845313345
-
The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; A review
-
Eskens FA, Verweij J. The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; a review. Eur J Cancer 2006;42:3127-39.
-
(2006)
Eur J Cancer
, vol.42
, pp. 3127-39
-
-
Eskens, F.A.1
Verweij, J.2
-
70
-
-
34347268452
-
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
-
Garfield DH, Hercbergs A, Davis PJ. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst 2007;99:975-6.
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 975-6
-
-
Garfield, D.H.1
Hercbergs, A.2
Davis, P.J.3
-
71
-
-
0033535580
-
Central hypothyroidism associated with retinoid X receptor-selective ligands
-
Sherman SI, Gopal J, Haugen BR, Chiu AC, Whaley K, Nowlakha P, et al. Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 1999;340:1075-9.
-
(1999)
N Engl J Med
, vol.340
, pp. 1075-9
-
-
Sherman, S.I.1
Gopal, J.2
Haugen, B.R.3
Chiu, A.C.4
Whaley, K.5
Nowlakha, P.6
-
72
-
-
0028091085
-
Dosimetry of radiation scattered to thyroid gland from prophylactic cranial irradiation for childhood leukemia
-
Bessho R, Ohta K, Akanuma A, Sakata K. Dosimetry of radiation scattered to thyroid gland from prophylactic cranial irradiation for childhood leukemia. Pediatr Hematol Oncol 1994;11:47-53.
-
(1994)
Pediatr Hematol Oncol
, vol.11
, pp. 47-53
-
-
Bessho, R.1
Ohta, K.2
Akanuma, A.3
Sakata, K.4
-
73
-
-
34247157199
-
The natural history of thyroid function abnormalities after treatment for childhood cancer
-
Madanat LM, Lahteenmaki PM, Alin J, Salmi TT. The natural history of thyroid function abnormalities after treatment for childhood cancer. Eur J Cancer 2007;43:1161-70.
-
(2007)
Eur J Cancer
, vol.43
, pp. 1161-70
-
-
Madanat, L.M.1
Lahteenmaki, P.M.2
Alin, J.3
Salmi, T.T.4
-
74
-
-
2942622484
-
Radiotherapy-induced thyroid disorders
-
Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R. Radiotherapy-induced thyroid disorders. Cancer Treat Rev 2004;30:369-84.
-
(2004)
Cancer Treat Rev
, vol.30
, pp. 369-84
-
-
Jereczek-Fossa, B.A.1
Alterio, D.2
Jassem, J.3
Gibelli, B.4
Tradati, N.5
Orecchia, R.6
-
75
-
-
0030872451
-
Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: A comparison of hyperfractionated versus conventional radiotherapy
-
Chin D, Sklar C, Donahue B, Uli N, Geneiser N, Allen J, et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer 1997;80:798-804.
-
(1997)
Cancer
, vol.80
, pp. 798-804
-
-
Chin, D.1
Sklar, C.2
Donahue, B.3
Uli, N.4
Geneiser, N.5
Allen, J.6
-
76
-
-
0026030707
-
Endocrine and reproductive dysfunction following fractionated total body irradiation in adults
-
Littley MD, Shalet SM, Morgenstern GR, Deakin DP. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Quart J Med 1991;78:265-74.
-
(1991)
Quart J Med
, vol.78
, pp. 265-74
-
-
Littley, M.D.1
Shalet, S.M.2
Morgenstern, G.R.3
Deakin, D.P.4
-
77
-
-
10344248700
-
Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence
-
Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T, et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab 2004;89:5981-6.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 5981-6
-
-
Ishiguro, H.1
Yasuda, Y.2
Tomita, Y.3
Shinagawa, T.4
Shimizu, T.5
Morimoto, T.6
-
78
-
-
0025835720
-
Thyroid diseases after treatment of Hodgkin's disease
-
Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
-
(1991)
N Engl J Med
, vol.325
, pp. 599-605
-
-
Hancock, S.L.1
Cox, R.S.2
McDougall, I.R.3
-
80
-
-
0021670923
-
Grave's disease with ophthalmopathy following radiotherapy for Hodgkin's disease
-
Jacobson DR, Fleming BJ. Grave's disease with ophthalmopathy following radiotherapy for Hodgkin's disease. Am J Med Sci 1984;288:217-20.
-
(1984)
Am J Med Sci
, vol.288
, pp. 217-20
-
-
Jacobson, D.R.1
Fleming, B.J.2
-
82
-
-
34247174577
-
Thyroid disorders during interferon alpha therapy in 625 patients with chronic hepatitis C: A prospective cohort study
-
Kabbaj N, Guedira MM, El Atmani H, El Alaoui M, Mohammadi M, Benabed K, et al. Thyroid disorders during interferon alpha therapy in 625 patients with chronic hepatitis C: a prospective cohort study. Ann Endocrinol (Paris) 2006;67:343-7.
-
(2006)
Ann Endocrinol (Paris)
, vol.67
, pp. 343-7
-
-
Kabbaj, N.1
Guedira, M.M.2
El Atmani, H.3
El Alaoui, M.4
Mohammadi, M.5
Benabed, K.6
-
83
-
-
34249034906
-
Two cases of hyperthyroidism induced by interferon-alpha therapy for renal cell carcinoma
-
article in Japanese
-
Umemoto S, Izumi K, Kanno H. Two cases of hyperthyroidism induced by interferon-alpha therapy for renal cell carcinoma. Hinyokika Kiyo 2007;53:225-9. (article in Japanese).
-
(2007)
Hinyokika Kiyo
, vol.53
, pp. 225-9
-
-
Umemoto, S.1
Izumi, K.2
Kanno, H.3
-
84
-
-
0033709897
-
Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the childhood cancer survivor study
-
Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the childhood cancer survivor study. J Clin Endocrinol Metab 2000;85:3227-32.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 3227-32
-
-
Sklar, C.1
Whitton, J.2
Mertens, A.3
Stovall, M.4
Green, D.5
Marina, N.6
-
85
-
-
0030443950
-
Acute radiation thyroiditis
-
Nishiyama K, Kozuka T, Higashihara T, Miyauchi K, Okagawa K. Acute radiation thyroiditis. Int J Radiat Oncol Biol Phys 1996;6:1221-4.
-
(1996)
Int J Radiat Oncol Biol Phys
, vol.6
, pp. 1221-4
-
-
Nishiyama, K.1
Kozuka, T.2
Higashihara, T.3
Miyauchi, K.4
Okagawa, K.5
-
86
-
-
26444551209
-
Drug-induced hypomagnesaemia: Scope and management
-
Atsmon J, Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Safety 2005;28:763-88.
-
(2005)
Drug Safety
, vol.28
, pp. 763-88
-
-
Atsmon, J.1
Dolev, E.2
-
87
-
-
0343035726
-
Hypomagnesemic hypokalemia and hypocalcemia: Clinical and laboratory characteristics
-
Elisaf M, Milionis H, Siamipoulos KC. Hypomagnesemic hypokalemia and hypocalcemia: clinical and laboratory characteristics. Miner Electrolyte Metab 1997;23:105-12.
-
(1997)
Miner Electrolyte Metab
, vol.23
, pp. 105-12
-
-
Elisaf, M.1
Milionis, H.2
Siamipoulos, K.C.3
-
89
-
-
33845660889
-
Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system
-
Stöhr W, Paulides M, Bielack S, Jürgens H, Koscielniak E, Rossi R, et al. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system. Pediatr Blood Cancer 2007;48:140-7.
-
(2007)
Pediatr Blood Cancer
, vol.48
, pp. 140-7
-
-
Stöhr, W.1
Paulides, M.2
Bielack, S.3
Jürgens, H.4
Koscielniak, E.5
Rossi, R.6
-
91
-
-
0037361961
-
Acute tumor lysis syndrome in solid tumors-a case report and review of the literature
-
Baeksgaard K, Sorensen JB. Acute tumor lysis syndrome in solid tumors-a case report and review of the literature. Cancer Chemother Pharmacol 2003;51:187-92.
-
(2003)
Cancer Chemother Pharmacol
, vol.51
, pp. 187-92
-
-
Baeksgaard, K.1
Sorensen, J.B.2
-
92
-
-
0021252317
-
Interferons-its method of administration and adverse effect related to pharmacokinetics
-
article in Japanese
-
Furue H. Interferons-its method of administration and adverse effect related to pharmacokinetics. Gan to Kagaku Ryoho 1984;11:186-93. (article in Japanese).
-
(1984)
Gan to Kagaku Ryoho
, vol.11
, pp. 186-93
-
-
Furue, H.1
-
93
-
-
1242271412
-
Hypocalcemia and azootemia associated with zoledronic acid and interferon alfa
-
Epub 2004 Jan 23
-
Tanvetyanon T, Choudhury AM. Hypocalcemia and azootemia associated with zoledronic acid and interferon alfa. Ann Pharmacother 2004;38:418-21. (Epub 2004 Jan 23).
-
(2004)
Ann Pharmacother
, vol.38
, pp. 418-21
-
-
Tanvetyanon, T.1
Choudhury, A.M.2
-
94
-
-
0016550087
-
A case of hyperparathyroidism associated with radiation to the head and neck area
-
Rosen IB, Strawbridge HG, Bain J. A case of hyperparathyroidism associated with radiation to the head and neck area. Cancer 1975;36:1111-4.
-
(1975)
Cancer
, vol.36
, pp. 1111-4
-
-
Rosen, I.B.1
Strawbridge, H.G.2
Bain, J.3
-
95
-
-
10644281477
-
The coming of age of radiation-induced hyperparathyroidism: Evolving patterns of thyroid and parathyroid disease after head and neck irradiation
-
Stephen AE, Chen KT, Milas M, Siperstein AE. The coming of age of radiation-induced hyperparathyroidism: evolving patterns of thyroid and parathyroid disease after head and neck irradiation. Surgery 2004;136:1143-53.
-
(2004)
Surgery
, vol.136
, pp. 1143-53
-
-
Stephen, A.E.1
Chen, K.T.2
Milas, M.3
Siperstein, A.E.4
-
96
-
-
0021630054
-
A clinical evaluation of radiation-induced hyperparathyroidism based on 148 surgically treated patients
-
Hedman I, Hansson G, Lundberg LM, Tisel LE. A clinical evaluation of radiation-induced hyperparathyroidism based on 148 surgically treated patients. World J Surg 1984;8:96-105.
-
(1984)
World J Surg
, vol.8
, pp. 96-105
-
-
Hedman, I.1
Hansson, G.2
Lundberg, L.M.3
Tisel, L.E.4
-
97
-
-
0018711146
-
Hyperparathyroidism after radiation of the neck: A case report and review of the literature
-
Fiorica V, Males JL. Hyperparathyroidism after radiation of the neck: a case report and review of the literature. Am J Med Sci 1979;278:223-8.
-
(1979)
Am J Med Sci
, vol.278
, pp. 223-8
-
-
Fiorica, V.1
Males, J.L.2
-
98
-
-
0032949850
-
Parathyroid and thyroid function five years after treatment of laryngeal and hypopharyngeal carcinoma
-
Thorp MA, Levitt NS, Mortimore S, Isaacs S. Parathyroid and thyroid function five years after treatment of laryngeal and hypopharyngeal carcinoma. Clin Otolaryngol Allied Sci 1999;24:104-8.
-
(1999)
Clin Otolaryngol Allied Sci
, vol.24
, pp. 104-8
-
-
Thorp, M.A.1
Levitt, N.S.2
Mortimore, S.3
Isaacs, S.4
-
99
-
-
33947585917
-
Adrenal toxicity: A strategy for assessment of functional toxicity to the adrenal cortex and steroidogenesis
-
Harvey PW, Everett DJ, Springall CJ. Adrenal toxicity: a strategy for assessment of functional toxicity to the adrenal cortex and steroidogenesis. J Appl Toxicol 2007;27:103-15.
-
(2007)
J Appl Toxicol
, vol.27
, pp. 103-15
-
-
Harvey, P.W.1
Everett, D.J.2
Springall, C.J.3
-
100
-
-
0036883597
-
Endocrine complications in pediatric patients with acute lymphoblastic leukemia
-
Howard SC, Pui CH. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev 2002;16:225-43.
-
(2002)
Blood Rev
, vol.16
, pp. 225-43
-
-
Howard, S.C.1
Pui, C.H.2
-
101
-
-
17644420335
-
Mitotane for adrenocortical carcinoma treatment
-
Hahner S, Fassnacht M. Mitotane for adrenocortical carcinoma treatment. Curr Opin Investig Drugs 2005;6:386-94.
-
(2005)
Curr Opin Investig Drugs
, vol.6
, pp. 386-94
-
-
Hahner, S.1
Fassnacht, M.2
-
103
-
-
33744952176
-
Clinical review: Adrenocorticol carcinoma: Clinical update
-
Allolio B, Fassnacht M. Clinical review: Adrenocorticol carcinoma: clinical update. J Clin Endocrinol Metab 2006;91:2027-37.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 2027-37
-
-
Allolio, B.1
Fassnacht, M.2
-
104
-
-
34249996792
-
Adjuvant mitotane therapy of adrenal cancer-use and controversy
-
Schteingart DE. Adjuvant mitotane therapy of adrenal cancer-use and controversy. N Engl J Med 2007;356:2415-8.
-
(2007)
N Engl J Med
, vol.356
, pp. 2415-8
-
-
Schteingart, D.E.1
-
105
-
-
0013864912
-
Two cases of busulfan toxicity
-
Smalley RV, Wall RL. Two cases of busulfan toxicity. Ann Intern Med 1966;64:154-64.
-
(1966)
Ann Intern Med
, vol.64
, pp. 154-64
-
-
Smalley, R.V.1
Wall, R.L.2
-
106
-
-
0013808120
-
Cytologic dysplasia occurring after busulfan (Myleran) therapy. A syndrome resembling adrenocorticol insufficiency and atrophic bronchitis
-
Ward HN, Konikov N, Reinhard EH. Cytologic dysplasia occurring after busulfan (Myleran) therapy. A syndrome resembling adrenocorticol insufficiency and atrophic bronchitis. Ann Intern Med 1965;63:654-60.
-
(1965)
Ann Intern Med
, vol.63
, pp. 654-60
-
-
Ward, H.N.1
Konikov, N.2
Reinhard, E.H.3
-
107
-
-
0344974110
-
A syndrome resembling adrenal corticol insufficiency associated with long term busulfan (Myleran) therapy
-
Kyle RA, Schwartz RS, Oliner HL, Dameshek W. A syndrome resembling adrenal corticol insufficiency associated with long term busulfan (Myleran) therapy. Blood 1961;18:497-510.
-
(1961)
Blood
, vol.18
, pp. 497-510
-
-
Kyle, R.A.1
Schwartz, R.S.2
Oliner, H.L.3
Dameshek, W.4
-
108
-
-
0014021710
-
Syndrome resembling Addison's disease following prolonged treatment with busulphan
-
Harrold BP. Syndrome resembling Addison's disease following prolonged treatment with busulphan. Br Med J 1966;1:463-4.
-
(1966)
Br Med J
, vol.1
, pp. 463-4
-
-
Harrold, B.P.1
-
109
-
-
36749077812
-
-
GlaxoSmithKline Jan GlaxoSmithKline
-
GlaxoSmithKline. Myleran, Prescribing Information. Jan 2004. GlaxoSmithKline.
-
(2004)
Myleran, Prescribing Information
-
-
-
110
-
-
33947423448
-
Approval summary: Sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma
-
Goodman VL, Rock EP, Dagher R, Ramchandani RP, Abraham S, Gobburu JV, et al. Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma. Clin Cancer Res 2007;13:1367-73.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 1367-73
-
-
Goodman, V.L.1
Rock, E.P.2
Dagher, R.3
Ramchandani, R.P.4
Abraham, S.5
Gobburu, J.V.6
-
111
-
-
0029806192
-
Mineralocorticoid insufficiency due to suramin therapy
-
Kobayashi K, Weiss RE, Vogelzang NJ, Vokes EE, Janisch L, Ratain MJ. Mineralocorticoid insufficiency due to suramin therapy. Cancer 1996;78:2411-20.
-
(1996)
Cancer
, vol.78
, pp. 2411-20
-
-
Kobayashi, K.1
Weiss, R.E.2
Vogelzang, N.J.3
Vokes, E.E.4
Janisch, L.5
Ratain, M.J.6
-
112
-
-
0026337882
-
Suramin and the human adrenocortex: Results of experimental and clinical studies
-
Dorfinger K, Niederle B, Vierhapper H, Astrid W, Czernin S, Nowotny P, et al. Suramin and the human adrenocortex: results of experimental and clinical studies. Surgery 1991;110:1100-5.
-
(1991)
Surgery
, vol.110
, pp. 1100-5
-
-
Dorfinger, K.1
Niederle, B.2
Vierhapper, H.3
Astrid, W.4
Czernin, S.5
Nowotny, P.6
-
113
-
-
0029054915
-
Induction of adrenal suppression by megestrol acetate in patients with AIDS
-
Leinung MC, Liporace R, Miller CH. Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med 1995;122:843-5.
-
(1995)
Ann Intern Med
, vol.122
, pp. 843-5
-
-
Leinung, M.C.1
Liporace, R.2
Miller, C.H.3
-
114
-
-
1842691403
-
Stem sell transplantation: Supportive care and long-term complications
-
Wingard JR, Vogelsang GB, Deeg HJ. Stem sell transplantation: supportive care and long-term complications. Hematology 2002;1:422-44.
-
(2002)
Hematology
, vol.1
, pp. 422-44
-
-
Wingard, J.R.1
Vogelsang, G.B.2
Deeg, H.J.3
-
115
-
-
33747689876
-
Endocrinological late effects following radiotherapy and chemotherapy of childhood brain tumours
-
Schmiegelow M. Endocrinological late effects following radiotherapy and chemotherapy of childhood brain tumours. Dan Med Bull 2006;53:326-41.
-
(2006)
Dan Med Bull
, vol.53
, pp. 326-41
-
-
Schmiegelow, M.1
-
116
-
-
33846892734
-
Endocrine effects of breast cancer treatment
-
Stricker CT. Endocrine effects of breast cancer treatment. Sem Oncol Nurs 2007;23:55-70.
-
(2007)
Sem Oncol Nurs
, vol.23
, pp. 55-70
-
-
Stricker, C.T.1
-
117
-
-
34247546252
-
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer
-
Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 2006;24:5769-79.
-
(2006)
J Clin Oncol
, vol.24
, pp. 5769-79
-
-
Walshe, J.M.1
Denduluri, N.2
Swain, S.M.3
-
118
-
-
0024429171
-
Gonadal dysfunction due to cis-platinum
-
Wallace WH, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR, Price DA. Gonadal dysfunction due to cis-platinum. Med Pediatr Oncol 1989;17:409-13.
-
(1989)
Med Pediatr Oncol
, vol.17
, pp. 409-13
-
-
Wallace, W.H.1
Shalet, S.M.2
Crowne, E.C.3
Morris-Jones, P.H.4
Gattamaneni, H.R.5
Price, D.A.6
-
119
-
-
34248545711
-
Gonadal dysfunction and fertility problems in cancer survivors
-
Brydoy M, Fossa SD, Dahl O, Bjoro T. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol 2007;46:480-9.
-
(2007)
Acta Oncol
, vol.46
, pp. 480-9
-
-
Brydoy, M.1
Fossa, S.D.2
Dahl, O.3
Bjoro, T.4
-
120
-
-
0021944234
-
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs. ABVD
-
Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs. ABVD. Eur J Cancer Clin Oncol 1985;21:601-5.
-
(1985)
Eur J Cancer Clin Oncol
, vol.21
, pp. 601-5
-
-
Viviani, S.1
Santoro, A.2
Ragni, G.3
Bonfante, V.4
Bestetti, O.5
Bonadonna, G.6
-
121
-
-
0031647278
-
Gonadal damage from chemotherapy and radiotherapy
-
Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 1998;27:927-43.
-
(1998)
Endocrinol Metab Clin North Am
, vol.27
, pp. 927-43
-
-
Howell, S.1
Shalet, S.2
-
122
-
-
0032921613
-
Testicular function after cytotoxic chemotherapy; Evidence of Leydig cell insufficiency
-
Howell SJ, Radford JA, Ryder WD, Shalet SM. Testicular function after cytotoxic chemotherapy; evidence of Leydig cell insufficiency. J Clin Oncol 1999;17:493-8.
-
(1999)
J Clin Oncol
, vol.17
, pp. 493-8
-
-
Howell, S.J.1
Radford, J.A.2
Ryder, W.D.3
Shalet, S.M.4
-
123
-
-
0035312763
-
The impact of chemotherapy on Leydig cell function in long-term survivors of germ cell tumors
-
Gerl A, Muhlbayer D, Hansmann G, Mraz W, Hiddemann W. The impact of chemotherapy on Leydig cell function in long-term survivors of germ cell tumors. Cancer 2001;91:1297-1303.
-
(2001)
Cancer
, vol.91
, pp. 1297-1303
-
-
Gerl, A.1
Muhlbayer, D.2
Hansmann, G.3
Mraz, W.4
Hiddemann, W.5
-
124
-
-
0034924693
-
Endocrine complications of neoplastic diseases in children and adolescents
-
Gleeson HK, Shalet SM. Endocrine complications of neoplastic diseases in children and adolescents. Curr Opin Pediatr 2001;13:346-51.
-
(2001)
Curr Opin Pediatr
, vol.13
, pp. 346-51
-
-
Gleeson, H.K.1
Shalet, S.M.2
-
125
-
-
20444454245
-
Spermatogenesis after cancer treatment: Damage and recovery
-
Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005;34:12-7.
-
(2005)
J Natl Cancer Inst Monogr
, vol.34
, pp. 12-7
-
-
Howell, S.J.1
Shalet, S.M.2
-
126
-
-
0029825294
-
Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease
-
Heikens J, Behrendt H, Adriaanse R, Berghout A. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease. Cancer 1996;78:2020-4.
-
(1996)
Cancer
, vol.78
, pp. 2020-4
-
-
Heikens, J.1
Behrendt, H.2
Adriaanse, R.3
Berghout, A.4
-
127
-
-
0029805736
-
Evaluation of long-term toxicity after chemotherapy for testicular cancer
-
Bokemeyer C, Berger CC, Kuczyk MA, Schmoll HJ. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 1996;14:2923-32.
-
(1996)
J Clin Oncol
, vol.14
, pp. 2923-32
-
-
Bokemeyer, C.1
Berger, C.C.2
Kuczyk, M.A.3
Schmoll, H.J.4
-
128
-
-
0032533933
-
The effects of etoposide on testicular function in boys treated for Hodgkin's disease
-
Bramswig GL, Shlegel W, Jurgens H, Schellong G. The effects of etoposide on testicular function in boys treated for Hodgkin's disease. Cancer 1998;83:2217-22.
-
(1998)
Cancer
, vol.83
, pp. 2217-22
-
-
Bramswig, G.L.1
Shlegel, W.2
Jurgens, H.3
Schellong, G.4
-
129
-
-
34548858332
-
The quality of life and hormonal disturbances in testicular cancer survivors in cisplatin era
-
Wiechno P, Demkow T, Kubiak K, Sadowska M, Kaminska J. The quality of life and hormonal disturbances in testicular cancer survivors in cisplatin era. Eur Urol 2007;52:1448-54.
-
(2007)
Eur Urol
, vol.52
, pp. 1448-54
-
-
Wiechno, P.1
Demkow, T.2
Kubiak, K.3
Sadowska, M.4
Kaminska, J.5
-
130
-
-
0029876301
-
Endocrinological late effects after chemotherapy for testicular cancer
-
Berger CC, Bokemeyer C, Schuppert F, Schmoll HJ. Endocrinological late effects after chemotherapy for testicular cancer. Br J Cancer 1996;73:1108-14.
-
(1996)
Br J Cancer
, vol.73
, pp. 1108-14
-
-
Berger, C.C.1
Bokemeyer, C.2
Schuppert, F.3
Schmoll, H.J.4
-
131
-
-
0030749006
-
Frequent and frequently overlooked: Treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors
-
Arlt W, Hove U, Muller B, Reincke M, Berweiler U, Schwab F, et al. Frequent and frequently overlooked: treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors. Neurology 1997;47:498-506.
-
(1997)
Neurology
, vol.47
, pp. 498-506
-
-
Arlt, W.1
Hove, U.2
Muller, B.3
Reincke, M.4
Berweiler, U.5
Schwab, F.6
-
132
-
-
0001538384
-
Menstrual disruption in premenopausal breast cancer patients receiving CMF (IV) vs. AC adjuvant chemotherapy
-
Bryce CJ, Shenkier T, Gelmon K. Menstrual disruption in premenopausal breast cancer patients receiving CMF (IV) vs. AC adjuvant chemotherapy. Breast Cancer Res Treat 1998;50:284.
-
(1998)
Breast Cancer Res Treat
, vol.50
, pp. 284
-
-
Bryce, C.J.1
Shenkier, T.2
Gelmon, K.3
-
133
-
-
0036863752
-
Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer
-
Minton SE, Munster PN. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control 2002;9:466-72.
-
(2002)
Cancer Control
, vol.9
, pp. 466-72
-
-
Minton, S.E.1
Munster, P.N.2
-
134
-
-
0029864362
-
Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer
-
Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718-29.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1718-29
-
-
Bines, J.1
Oleske, D.M.2
Cobleigh, M.A.3
-
135
-
-
33644978457
-
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: A prospective study
-
Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006;24:1045-51.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1045-51
-
-
Petrek, J.A.1
Naughton, M.J.2
Case, L.D.3
Paskett, E.D.4
Naftalis, E.Z.5
Singletary, S.E.6
-
136
-
-
0036863752
-
Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer
-
Minton SE, Munster PN. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control 2002;9:466-72.
-
(2002)
Cancer Control
, vol.9
, pp. 466-72
-
-
Minton, S.E.1
Munster, P.N.2
-
137
-
-
32944456476
-
The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors
-
Knobf MT. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors. The Oncologist 2006;11:96-110.
-
(2006)
The Oncologist
, vol.11
, pp. 96-110
-
-
Knobf, M.T.1
-
138
-
-
34147175631
-
The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane
-
Tham YL, Sexton K, Weiss H, Elledge R, Friedman LC, Kramer R. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol 2007;30:126-32.
-
(2007)
Am J Clin Oncol
, vol.30
, pp. 126-32
-
-
Tham, Y.L.1
Sexton, K.2
Weiss, H.3
Elledge, R.4
Friedman, L.C.5
Kramer, R.6
-
139
-
-
1842479985
-
Sexual functioning in cancer patients
-
Monga U. Sexual functioning in cancer patients. Sex Disabil 2002;20:277-95.
-
(2002)
Sex Disabil
, vol.20
, pp. 277-95
-
-
Monga, U.1
-
140
-
-
0036721205
-
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases
-
Tauchmanova L, Selleri C, DeRosa G, Pagano L, Orio F, Lombardi G, et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 2002;95:1076-84.
-
(2002)
Cancer
, vol.95
, pp. 1076-84
-
-
Tauchmanova, L.1
Selleri, C.2
Derosa, G.3
Pagano, L.4
Orio, F.5
Lombardi, G.6
-
141
-
-
0031982804
-
Ovarian function after bone marrow transplantation during childhood
-
Thibaud E, Rodriguez-Macias K, Trivin C, Esperou H, Michon J, Brauner R. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 1998;21:287-90.
-
(1998)
Bone Marrow Transplant
, vol.21
, pp. 287-90
-
-
Thibaud, E.1
Rodriguez-Macias, K.2
Trivin, C.3
Esperou, H.4
Michon, J.5
Brauner, R.6
-
142
-
-
0002426417
-
Adverse effects of treatment: Gonadal dysfunction
-
5 Lippincott-Raven New York
-
Meistrich ML, Vassilopoulou-Sellin R, Lipschultz LI. Adverse effects of treatment: gonadal dysfunction. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer, principles and practice of oncology. 5th ed. New York: Lippincott-Raven; 1997. p. 2758-73.
-
(1997)
Cancer, Principles and Practice of Oncology
, pp. 2758-73
-
-
Meistrich, M.L.1
Vassilopoulou-Sellin, R.2
Lipschultz, L.I.3
De Vita, V.T.4
Hellman, S.5
Rosenberg, S.A.6
-
143
-
-
85033036570
-
Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic Acid receptors
-
Standeven AM, Beard RL, Johnson AT, Boehm MF, Escobar M, Heyman RA, et al. Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic Acid receptors. Fundam Appl Toxicol 1996;33:264-72.
-
(1996)
Fundam Appl Toxicol
, vol.33
, pp. 264-72
-
-
Standeven, A.M.1
Beard, R.L.2
Johnson, A.T.3
Boehm, M.F.4
Escobar, M.5
Heyman, R.A.6
-
144
-
-
0035235308
-
Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma
-
Dillman RO, Shea WM, Tai DF, Mahdavi K, Barth NM, Kharkar BR, et al. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma. Neuro-Oncol 2001;3:35-41.
-
(2001)
Neuro-Oncol
, vol.3
, pp. 35-41
-
-
Dillman, R.O.1
Shea, W.M.2
Tai, D.F.3
Mahdavi, K.4
Barth, N.M.5
Kharkar, B.R.6
-
145
-
-
0037117563
-
High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic therapy for acne: A pharmacogenetic study
-
Rodondi N, Darioli R, Ramelet AA, Hohl D, Lenain V, Perdrix J, et al. High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic therapy for acne: a pharmacogenetic study. Ann Intern Med 2002;136:582-9.
-
(2002)
Ann Intern Med
, vol.136
, pp. 582-9
-
-
Rodondi, N.1
Darioli, R.2
Ramelet, A.A.3
Hohl, D.4
Lenain, V.5
Perdrix, J.6
-
146
-
-
0347757248
-
Short-term administration of isotretinoin elevates plasma triglyceride concentrations without affecting insulin sensitivity in health humans
-
Stoll D, Binnert C, Mooser V, Tappy L. Short-term administration of isotretinoin elevates plasma triglyceride concentrations without affecting insulin sensitivity in health humans. Metabolism 2004;53:4-10.
-
(2004)
Metabolism
, vol.53
, pp. 4-10
-
-
Stoll, D.1
Binnert, C.2
Mooser, V.3
Tappy, L.4
-
147
-
-
36749000799
-
-
Hoffman-La Roche Inc. Roferon-A Sept
-
Hoffman-La Roche Inc. Roferon-A, Complete product information. Sept 2003.
-
(2003)
Complete Product Information
-
-
-
148
-
-
0029033933
-
Hypertriglyceridemia may be severe in CML patients treated with interferon-alpha
-
Peñarrubia MJ, Steegmann JL, Lavilla E, Casado F, Requena MJ, Picõ M, et al. Hypertriglyceridemia may be severe in CML patients treated with interferon-alpha. Am J Hematol 1995;49:240-1.
-
(1995)
Am J Hematol
, vol.49
, pp. 240-1
-
-
Peñarrubia, M.J.1
Steegmann, J.L.2
Lavilla, E.3
Casado, F.4
Requena, M.J.5
Picõ, M.6
-
149
-
-
4644235349
-
Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma
-
Wong SF, Jakowatz JG, Taheri R. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma. Ann Pharmacother 2004;38:1655-9.
-
(2004)
Ann Pharmacother
, vol.38
, pp. 1655-9
-
-
Wong, S.F.1
Jakowatz, J.G.2
Taheri, R.3
-
150
-
-
0027082709
-
Hypercholesterolemia after chemotherapy for testis cancer
-
Raghavan D, Cox K, Childs A, Grygiel J, Sullivan D. Hypercholesterolemia after chemotherapy for testis cancer. J Clin Oncol 1992;10:1375-9.
-
(1992)
J Clin Oncol
, vol.10
, pp. 1375-9
-
-
Raghavan, D.1
Cox, K.2
Childs, A.3
Grygiel, J.4
Sullivan, D.5
-
151
-
-
0027058003
-
Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer
-
Gietema JA, Sleijfer DT, Willemse PH, Scraffordt Koops H, van Ittersum E, Verschuren WM, et al. Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer. Ann Intern Med 1992;116:709-15.
-
(1992)
Ann Intern Med
, vol.116
, pp. 709-15
-
-
Gietema, J.A.1
Sleijfer, D.T.2
Willemse, P.H.3
Scraffordt Koops, H.4
Van Ittersum, E.5
Verschuren, W.M.6
-
152
-
-
0036837269
-
The lack of long-term effect of cisplatin based combination chemotherapy on serum cholesterol for treatment of testicular cancer
-
Fenton DW, Verma S, Venner P, Sawhney R, Mackey JR. The lack of long-term effect of cisplatin based combination chemotherapy on serum cholesterol for treatment of testicular cancer. J Urol 2002;168:1971-4.
-
(2002)
J Urol
, vol.168
, pp. 1971-4
-
-
Fenton, D.W.1
Verma, S.2
Venner, P.3
Sawhney, R.4
MacKey, J.R.5
-
153
-
-
0026333581
-
Mitotane administration: An unusual cause of hypercholesterolemia
-
Vassilopoulou-Sellin R, Samaan NA. Mitotane administration: an unusual cause of hypercholesterolemia. Horm Metab Res 1991;23:619-20.
-
(1991)
Horm Metab Res
, vol.23
, pp. 619-20
-
-
Vassilopoulou-Sellin, R.1
Samaan, N.A.2
-
154
-
-
16544372656
-
13-cis Retinoic acid in head and neck cancer chemoprevention: Results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group
-
Toma S, Bonelli L, Sartoris A, Mira E, Antonelli A, Beatrice F, et al. 13-cis Retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Oncol Rep 2004;11:1297-305.
-
(2004)
Oncol Rep
, vol.11
, pp. 1297-305
-
-
Toma, S.1
Bonelli, L.2
Sartoris, A.3
Mira, E.4
Antonelli, A.5
Beatrice, F.6
-
155
-
-
0030937246
-
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia
-
Parsons SK, Skapek SX, Neufeld EJ, Kuhlman C, Young ML, Donnelly M, et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 1997;89:1886-95.
-
(1997)
Blood
, vol.89
, pp. 1886-95
-
-
Parsons, S.K.1
Skapek, S.X.2
Neufeld, E.J.3
Kuhlman, C.4
Young, M.L.5
Donnelly, M.6
-
156
-
-
0026494987
-
Possible mechanism and treatment of o,p′DDD-induced hypercholesterolaemia
-
Maher VM, Trainer PJ, Scoppola A, Anderson JV, Thompson GR, Besser GM. Possible mechanism and treatment of o,p′DDD-induced hypercholesterolaemia. Q J Med 1992;84:671-9.
-
(1992)
Q J Med
, vol.84
, pp. 671-9
-
-
Maher, V.M.1
Trainer, P.J.2
Scoppola, A.3
Anderson, J.V.4
Thompson, G.R.5
Besser, G.M.6
-
157
-
-
36749102276
-
Treatment of cutaneous T-cell lymphomas with bexarotene
-
article in Spanish
-
Lasa O, Izu R, Acebo E, Eguino P, Díaz-Pérez JL. Treatment of cutaneous T-cell lymphomas with bexarotene. Actas Dermo-sifiliogr 2006;97:102 (article in Spanish).
-
(2006)
Actas Dermo-sifiliogr
, vol.97
, pp. 102
-
-
Lasa, O.1
Izu, R.2
Acebo, E.3
Eguino, P.4
Díaz-Pérez, J.L.5
-
159
-
-
0141644220
-
Iatrogenic hyperlipidemia after l-asparaginase and glucocorticoid treatment in two children with acute lymphoblastic leukemia
-
article in Polish
-
Zalewska-Szewczyk B, Przybysz K, Kowalewska-Pietrzak M, Stolarska M, Bodalski J. Iatrogenic hyperlipidemia after l-asparaginase and glucocorticoid treatment in two children with acute lymphoblastic leukemia. Pol Merkur Lekarski 2003;15:256-8. (article in Polish).
-
(2003)
Pol Merkur Lekarski
, vol.15
, pp. 256-8
-
-
Zalewska-Szewczyk, B.1
Przybysz, K.2
Kowalewska-Pietrzak, M.3
Stolarska, M.4
Bodalski, J.5
-
160
-
-
11844254702
-
Severe hyperlipidemia in a child with acute lymphoblastic leukemia treated with l-asparaginase and prednisone
-
Athanassiadou F, Kourti M, Papageorgiou T, Stamou M, Makedou A, Boufidou A. Severe hyperlipidemia in a child with acute lymphoblastic leukemia treated with l-asparaginase and prednisone. Pediatr Int 2004;46:743-4.
-
(2004)
Pediatr Int
, vol.46
, pp. 743-4
-
-
Athanassiadou, F.1
Kourti, M.2
Papageorgiou, T.3
Stamou, M.4
Makedou, A.5
Boufidou, A.6
-
161
-
-
0028073479
-
Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase
-
Steinherz PG. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer 1994;74:3234-9.
-
(1994)
Cancer
, vol.74
, pp. 3234-9
-
-
Steinherz, P.G.1
-
162
-
-
1842480205
-
Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases
-
Iwamoto T, Kagawa Y, Naito Y, Kuzuhara S, Kojima M. Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases. Pharmacotherapy 2004;24:508-14.
-
(2004)
Pharmacotherapy
, vol.24
, pp. 508-14
-
-
Iwamoto, T.1
Kagawa, Y.2
Naito, Y.3
Kuzuhara, S.4
Kojima, M.5
-
163
-
-
0024764471
-
Hyperlipidemia after organ transplantation
-
Markell MS, Friedman EA. Hyperlipidemia after organ transplantation. Am J Med 1989;87:61N-7N.
-
(1989)
Am J Med
, vol.87
-
-
Markell, M.S.1
Friedman, E.A.2
-
164
-
-
0842291684
-
Everolimus/cyclosporine interactions on bile flow and biliary excretion of bile salts and cholesterol in rates
-
Deters M, Kirchner G, Koal T, Resch K, Kaever V. Everolimus/cyclosporine interactions on bile flow and biliary excretion of bile salts and cholesterol in rates. Dig Dis Sci 2004;49:30-7.
-
(2004)
Dig Dis Sci
, vol.49
, pp. 30-7
-
-
Deters, M.1
Kirchner, G.2
Koal, T.3
Resch, K.4
Kaever, V.5
-
165
-
-
33644866386
-
Dietary phytosterols reduce cyclosporine-induced hypercholesterolemia in apolipoprotein E-knockout mice
-
Moghadasian MH. Dietary phytosterols reduce cyclosporine-induced hypercholesterolemia in apolipoprotein E-knockout mice. Transplantation 2006;81:207-13.
-
(2006)
Transplantation
, vol.81
, pp. 207-13
-
-
Moghadasian, M.H.1
-
166
-
-
0037203550
-
Cytokine synergism in apoptosis: Its role in diabetes and cancer
-
Lee MS. Cytokine synergism in apoptosis: its role in diabetes and cancer. J Biochem Mol Biol 2002;35:54-60.
-
(2002)
J Biochem Mol Biol
, vol.35
, pp. 54-60
-
-
Lee, M.S.1
-
167
-
-
0024498659
-
Effect of interferon on glucose tolerance and insulin sensitivity
-
Koivisto VA, Pelkonen R, Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 1989;38:641-7.
-
(1989)
Diabetes
, vol.38
, pp. 641-7
-
-
Koivisto, V.A.1
Pelkonen, R.2
Cantell, K.3
-
168
-
-
0026794365
-
Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis
-
Fabris P, Betterle C, Floreani A, et al. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 1992;340:548.
-
(1992)
Lancet
, vol.340
, pp. 548
-
-
Fabris, P.1
Betterle, C.2
Floreani, A.3
-
169
-
-
0031714409
-
Interferon-alpha and development of type 1 diabetes: A case without insulin resistance
-
Tohda G, Oida K, Higashi S, Hayashi T, Miyamori I. Interferon-alpha and development of type 1 diabetes: a case without insulin resistance. Diabetes Care 1998;10:1774.
-
(1998)
Diabetes Care
, vol.10
, pp. 1774
-
-
Tohda, G.1
Oida, K.2
Higashi, S.3
Hayashi, T.4
Miyamori, I.5
-
170
-
-
0141650564
-
Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy
-
Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C. Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther 2003;18:549-58.
-
(2003)
Aliment Pharmacol Ther
, vol.18
, pp. 549-58
-
-
Fabris, P.1
Floreani, A.2
Tositti, G.3
Vergani, D.4
De Lalla, F.5
Betterle, C.6
-
171
-
-
0032030743
-
Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis
-
Fabris P, Betterle C, Greggio NA, Zanchetta R, Bosi E, Biasin MR, et al. Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. J Hepatol 1998;28:514-7.
-
(1998)
J Hepatol
, vol.28
, pp. 514-7
-
-
Fabris, P.1
Betterle, C.2
Greggio, N.A.3
Zanchetta, R.4
Bosi, E.5
Biasin, M.R.6
-
172
-
-
0036883597
-
Endocrine complications in pediatric patients with acute lymphoblastic leukemia
-
Howard SC, Pui CH. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev 2002;16:225-43.
-
(2002)
Blood Rev
, vol.16
, pp. 225-43
-
-
Howard, S.C.1
Pui, C.H.2
-
173
-
-
33749670337
-
Clinical challenges in caring for patients with diabetes and cancer
-
Psarakis HM. Clinical challenges in caring for patients with diabetes and cancer. Diabetes Spectr 2006;19:157-62.
-
(2006)
Diabetes Spectr
, vol.19
, pp. 157-62
-
-
Psarakis, H.M.1
-
175
-
-
0016269663
-
Clinical antitumor activity and toxicity of streptozocin (NSC-85998)
-
Schein PS, O, Connell MJ, Blom J, Hubbard S, Magrath IT, Bergevin P, et al. Clinical antitumor activity and toxicity of streptozocin (NSC-85998). Cancer 1974;34:993-1000.
-
(1974)
Cancer
, vol.34
, pp. 993-1000
-
-
Schein, P.S.O.1
Connell, M.J.2
Blom, J.3
Hubbard, S.4
Magrath, I.T.5
Bergevin, P.6
-
176
-
-
23844509197
-
Doxorubicin and streptozocin after failed biotherapy for neuroendocrine tumors
-
Pavel ME, Baum U, Hahn EG, Hensen J. Doxorubicin and streptozocin after failed biotherapy for neuroendocrine tumors. Int J Gastrointest Cancer 2005;35:179-85.
-
(2005)
Int J Gastrointest Cancer
, vol.35
, pp. 179-85
-
-
Pavel, M.E.1
Baum, U.2
Hahn, E.G.3
Hensen, J.4
-
177
-
-
0027468252
-
Drug-induced disorders of glucose tolerance
-
Pandit MK, Burke J, Gustafson AB, Minocha A, Peiris AN. Drug-induced disorders of glucose tolerance. Ann Intern Med 1993;118:529-39.
-
(1993)
Ann Intern Med
, vol.118
, pp. 529-39
-
-
Pandit, M.K.1
Burke, J.2
Gustafson, A.B.3
Minocha, A.4
Peiris, A.N.5
-
178
-
-
0021857492
-
Cyclosporin enhances diabetes induced by low-dose streptozotocin treatment in mice
-
Sestier C, Odent-Pogu S, Bonneville M, Maurel C, Lang F, Sai P. Cyclosporin enhances diabetes induced by low-dose streptozotocin treatment in mice. Immunol Lett 1985;10:57-60.
-
(1985)
Immunol Lett
, vol.10
, pp. 57-60
-
-
Sestier, C.1
Odent-Pogu, S.2
Bonneville, M.3
Maurel, C.4
Lang, F.5
Sai, P.6
-
179
-
-
34249779568
-
Temsirolimus, interferon alpha, or both for advanced renal-cell carcinoma
-
Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, et al. Temsirolimus, interferon alpha, or both for advanced renal-cell carcinoma. N Engl J Med 2007;356:2271-81.
-
(2007)
N Engl J Med
, vol.356
, pp. 2271-81
-
-
Hudes, G.1
Carducci, M.2
Tomczak, P.3
Dutcher, J.4
Figlin, R.5
Kapoor, A.6
-
180
-
-
36749046590
-
A phase II trial of temsirolimus in metastatic neuroendocrine carcinomas
-
NECs, Abstract no: 146 Jan. 27-9 Hollywood, FL, USA
-
Duran I, Le L, Saltman D, Singh W, Kocha R, Cheiken G, et al. A phase II trial of temsirolimus in metastatic neuroendocrine carcinomas (NECs, Abstract no: 146). 2005, Jan. 27-9. Gastrointestinal Cancers Symposium, Hollywood, FL, USA.
-
(2005)
Gastrointestinal Cancers Symposium
-
-
Duran, I.1
Le, L.2
Saltman, D.3
Singh, W.4
Kocha, R.5
Cheiken, G.6
-
181
-
-
33750510023
-
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
-
Duran I, Kortmansky J, Singh D, Hirte H, Kocha W, Goss G, et al. A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas. Br J Cancer 2006;95:1148-54.
-
(2006)
Br J Cancer
, vol.95
, pp. 1148-54
-
-
Duran, I.1
Kortmansky, J.2
Singh, D.3
Hirte, H.4
Kocha, W.5
Goss, G.6
-
182
-
-
23344449942
-
Prospective evaluation of renal function in pediatric and adult patients treated with high-dose ifosfamide, cistplatin and high-dose methotrexate
-
Ferrari S, Pieretti F, Verri E, Tolentinis L, Cedari M, Versari M, et al. Prospective evaluation of renal function in pediatric and adult patients treated with high-dose ifosfamide, cistplatin and high-dose methotrexate. Anticancer Drugs 2005;16:733-8.
-
(2005)
Anticancer Drugs
, vol.16
, pp. 733-8
-
-
Ferrari, S.1
Pieretti, F.2
Verri, E.3
Tolentinis, L.4
Cedari, M.5
Versari, M.6
-
183
-
-
0034014698
-
Risk factors for nephrotoxicity after ifosfamide treatment in children: A UKCCSG Late Effects Group study
-
Skinner R, Coterrill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. Br J Cancer 2000;82:1636-45.
-
(2000)
Br J Cancer
, vol.82
, pp. 1636-45
-
-
Skinner, R.1
Coterrill, S.J.2
Stevens, M.C.3
-
184
-
-
34047192071
-
-
Feuerstein M, editor New York, Springer
-
Feuerstein M, editor. Handbook of cancer survivorship. New York, Springer; 2007.
-
(2007)
Handbook of Cancer Survivorship
-
-
|